Corrigendum to "Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks" [Neurochem. Int. 138 (2020) 104777]
- PMID: 37085423
- DOI: 10.1016/j.neuint.2023.105525
Corrigendum to "Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks" [Neurochem. Int. 138 (2020) 104777]
Erratum for
-
Abrogating doxorubicin-induced chemobrain by immunomodulators IFN-beta 1a or infliximab: Insights to neuroimmune mechanistic hallmarks.Neurochem Int. 2020 Sep;138:104777. doi: 10.1016/j.neuint.2020.104777. Epub 2020 May 29. Neurochem Int. 2020. PMID: 32479984
Publication types
LinkOut - more resources
Full Text Sources